Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART621 for plaque psoriasis
ACTRN12608000148370Phase 2Completed
- Sponsor
- Arana Therapeutics
- Start
- Mar 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of placulumab in plaque psoriasis (4 arms), sponsored by Arana Therapeutics. Primary endpoint: Repeat dose safety. Started Mar 2008; status: completed.
02
Drugs
placulumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ACTRN12608000148370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000148370.